Research & Clinical Studies with Lycopene

References: Lycopene & Cardiovascular Diseases

[1] Rissanen T, Voutilainen Si Nyyssonen K Salonen JT. – Research Institute of Public Health, University of Kuopio, Kuopio, Finland 70211. Lycopene, atherosclerosis; and coronary heart disease. Exp Biol Med (Maywood) 2002 Nov;227(10):900-7
[2] Rao AV. – Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada M5S3E2. Lycopene, tomatoes; andthe prevention of coronary heart disease. Exp Biol Med (Maywood) 2002 Nov;227(10):908-13
[3] Voutilainen S Nurmi T, Mursu J, Rissanen TH.- Research Institute of Public Health and Department of Public Health and General Practice, University of Kuopio, Kuopio, Finland. Carotenoidsand cardiovascular health.Am J Cin Nutr. 2006 Jun;83(6):1265-71.
4 DasS Otani H, Maulik N, DasDK Cardiovascular Research Center, University of Connecticut School of Medicine, Farmington, CT 06030-1110, USA. Lycopene^ tomatoes; and coronary heart disease. Free RadicRes. 2005 Apr;39(4):449-55.
[6] Kohlmeier L, Kark JD, Gomez-GradaE Martin BQ Steck SE Kardinaal AF, Ringstad J, Thamm M, Masaev V, RemersmaR Martin-Moreno JM, Huttunen JK Kok FJ- Lycopene and myocardial infarction risk in the EURAM 1C Study. Am J Epidemiol 1997 Oct 15;146(8):618-626
7 Gerster H – Vitamin Research Department, F. Hoffmann-La Rbche Ltd, Basel, Switzerland. The potential role of lycopene for human health. J Am Coil Nutr 1997 Apr; 16(2): 109-126
8 Klipstein-Grobusch K, Launer LJ Geleijnse JM, Boeing H, Hofman A, Witteman JC- Department of Epidemiology & Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands. Sterum carotenoids and atherosclerosis; The Rotterdam Study. At herosclerosis 2000 Jan; 148(1):49-56
[9] Arab L, Steck S- School of PublicHealth, University of North Carolina, Chapel Hill. Lycopene and cardiovascular disease. Am J Gin Nutr2000 Jun;71(6Suppl):1691S5S; discussion 1696S7S
[10] Rao AV, Agarwal S- Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Ontario, Canada Role of antioxidant lycopene in cancer and heart disease JAmCoil Nutr 2000Oct; 19(5):563-9 Review
11 Hsueh YM, Wu WL, Huang YL, Chiou HY, Tseng CH, Chen CJ- Department of Public Health, School of Medicine, Taipei Medica College, Taiwan,    ROG    Low    serum    carotene    level    and    increased    risk of    ischemic heart    disease    related to    long-term arsenic exposure. At herosclerosis 1998 Dec;141(2):249-57
12 Agarwal S Rao AV – Department of Nutritional Sciences, University of Toronto, ON, Canada – Carotenoidsand chronic diseases Drug Metabol Drug Interact 2000;17(1-4):189-210
[13] Fuhrman B, Elis A, Aviram M. Hypocholesterolemic effect of lycopene and beta-carotene isrelated tosuppression of cholesterol synthesisand augmentation of LDLreceptor activity in macrophages: Biochem Biophys Res Commun 1997 Apr28 .
[14] Agarwal S Rao AV – Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Ont. Tomato lycopene and its role in human health and chronic diseases: CMAJ2000Sep 19; 163(6) :739-44
15 Frei B- Boston University School of Medicine, Whitaker Cardiovascular Institute, Massachusetts 02118, USA. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation.Cl’it Rev Food Sci Nutr 1995 Jan;35(1-2):83-98
[16] Street DA,    Cbmstock GW,    Salkeld    RM,    Schuep W,    Klag MJ    Sterum antioxidants and myocardial    infarction.    Are    low levels of carotenoidsand alpha-tocopherol risk factorsfor myocardial infarction? Circulation 1994 Sep;90(3):1154-1161
17 CockeyCD- Lycopene may contribute to heart health. AWHONN Lifelines 2002 Jun-Jui;6(3):206
18 Karimi G, Ramezani M, Abdi A. FVotective effects of lycopene and tomato extract against doxorubicin-induced cardiotoxicity. Phytother Res. 2005 Oct;19(10):912-4.
19 Willcox JK, Catignani GL Lazarus S – Dept. of Food Science, North Carolina State University, Raleigh 27695-7624, USA. Tomatoes and cardiovascular health. Cht Rev Food Sci Nutr 2003;43(1):1-18
[20] Osganian SK, Stampfer MJ, Rimm E Soiegelman D, Manson JE, Willett WC Dietary carotenoidsand risk of coronary artery disease in women. Am J Clin Nutr. 2003 Jun;77(6):1390-9.
[21] Peter W. de Leeuw & Aalt Bast – Tomato Extract for Hypertension? Editorial to ÔÇ£ The Effects of Natural Antioxidants from Tomato Extract in Treated but Uncontrolled Hypertena’ve FatientSÔÇÖ by E Paran et a. – Cardiovasc Drugs’Ther (2009) 23:107-108
[17] Rissanen T, Voutilainen ┬º Nyyssonen K Salonen R Salonen JT – Low plasma lycopene concentration isassociated with increased intima-media thicknessof the carotid artery wall. Arterioscler Thromb Vasc Biol 2000 Dec;20(12):2677-81
[19] Dugas TR Morel DW; Harrison EH – Impact of LDLcarotenoid and alpha-tocopherol content on LDLoxidation by endothelial cellsin culture- Journal of Lipid Research 1998, Vol 39, Iss5, pp999-1007
20 Aviram M, Fuhrman B – LDL oxidation by arterial wall macrophages depends on the oxidative statusin the lipoprotein and in the cells: role of prooxidantsvs antioxidants Mol Cell Bochem 1998 Nov;188(1-2):149-59
21 Plat J van Onselen EN, van Heugten MM, Mensink RP- Effectson serum lipids; lipoproteinsandfat soluble antioxidant concentrations of consumption frequency of margarinesand shorteningsenriched with plant stanol esters: Eur Jdin Nutr 2000 Sfep;54(9):671-7
22 Carroll YL Corridan BM, Morrissey PA- Lipoprotein carotenoid profiles and the susceptibility of low density lipoprotein to oxidative modification in healthy elderly volunteers: Eur JQin Nutr 2000 Jun;54(6):500-7
23 Giugliano D- Dipartimento di Gerontologia Geriatriae Malattie del Metabolismo, SecondaUniveratadi Napoli, Italy. Dietary antioxidants for cardiovascular prevention. Nutr Metab Crdiovasc Dis 2000 Feb;10(1):38-44
24 Martin KR Wu D, Meydani M – The effect of carotenoidson the expression of cell surface adhesion moleculesand binding of monocytesto human aortic endothelial cells: Atherosclerosis 2000 Jun;150(2):265-74
25 Upritchard JE, Sutherland WH, Mann JI – Effect of supplementation with tomato juice, vitamin E and vitamin Con LDL oxidation and products of inflammatory activity in type 2 diabetes: Diabetes Care 2000 Jun;23(6):733-8
26 Linseisen J Hoffmann J Riedl J Wolfram G – Effect of a Singje Oral Dose of Antioxidant Mixture (Vitamin E, Carotenoid^ on the Formation of Cholesterol Oxidation FVoductsafter ex vivo LDL Oxidation in Humans: Eur J Med Res 1998 Feb21;3(1/2):5-12
27 Fuhrman B, Volkova N, Rbsenblat M, Aviram M – Lycopene synergpstically inhibitsLDLoxidation in combination with vitamin E giabridin, rosmarinicaad, carnosicadd, or garlic: Antioxid Redox Signal 2000 Fall;2(3):491-506
28 Clinton, Si K; Qaff.N. E; Degroff, V. L; Hadley, C.W.; Harris, G. K; Miller, B. C; Schwartz, Si J – The consumption of processed tomato products enhances plasma lycopene concentrationsand reduces oxidative damage to lipoproteins in humans: FASEB Journal VOL. 15 NO. 4 March 7, 2001 PP. A297.
29 Rissanen TH, Voutilainen ┬º Nyyssonen K LakkaTA,    Svenius J    Salonen R Kaplan    GA,    Salonen    JT.    Research    Institute    of    Public Health, University of Kuopio, FOBox1627, FIN-70211, Kuopio, Fnland. Low serum lycopene concentration isassoaatedwithan excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study: Br J Nutr 2001 jun;85(6):749-54
30 Paran, Esther; Engelhard, Yehiel – Hypertension Unit, Sbroka University medical Center, Beer Sheva Israel – Effect of tomato’s lycopene on blood pressure, serum lipoproteins, plasma homocysteine and oxidative stress markers in grade I hypertensive patients: American Journal of Hypertension Vol. 14 N. 4 Part 2- April, 2001 PP. 141A. May 15-19, 2001
31 Tonomoto, Mariko; Maruyama, Chizuko; Imamura, Kayoko; Harada, Miho; Egami, Satoko; Baba, Naoko; Ayaori, Makoto; Inakuma, Takahiro; Ishikawa, Toshitsugu; Oshima, Shunji; Suzukawa, Michio – Japan – Effects of tomato juice consumption on plasma and lipoprotein carotenoid concentrationsand the susceptibility of low density lipoprotein to oxidative modification: Journal of Nutritional Science and Vitaminology VOL.47 N.3 June, 2001 PP. 213-221.
[32] Dexter L Morris, Stephen B. Kritchevsky ; CE Davis. Sferum Garotenoidsand Coronary Heart Disease. Jama 1994; Vol.272, N. 18.
[33] Gianetti J, Pedrinelli    R    Petruod    R Lazzerini    G,    DeC&terinaM,    Bellomo    G,    DeC&terinaR –    C.    N.    Rt Institute of Clinical    Physiology, University of Pisa, Italy. Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis: Am Heart J 2002 Mar;143(3):467-74
34 Ruiz Rejon F, Martin-Pena G, Granado F,Ruiz-Galiana J Blanco 1, OlmedillaB. – Sfervicio de Cbrdiologia, Sferviao de Medicina Interna, Hospita de Mostoles, Madrid, Span. Plasma status of retinol, alpha- and gamma-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study: Nutrition 2002 Jan;18(1):26-31
[35] A.Elisabeth Hak; Jng Ma; CalpumyaB.Fbwell; Hannia Campos; JMichael Gaziano; Walter C.Willet;Meier Stampfer. FVospective Study of Flasma CerotenoidsandTocopheroisin relation to risk of Ischemic Stroke: Journal of the American Heart Association. Stroke 2004; 35; 1584-1588 .
36 Tavani A, Gallus ┬º Negri E, Parpinel M, La VecchiaC – Istituto di Rcerche Farmacologche “Mario Negri”, Via Eritrea 62, Milan, 20157, Itay. Dietary intake of carotenoids and retinol and the risk of acute myocardial infarction in Italy: Free Radic Res. 2006 Jun;40(6):659-64.
37 Bansal P, GuptaSK, CjhaSK, Nandave M, Mittal R Kumari S] AryaDS – Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. Cardioprotective effect of lycopene in the experimental model of myocardial ischemia-reperfusion injury: Mol Cell Bochem. 2006 Apr 7.
[38] Engelhard YN, Gazer B, Paran E. – Hypertension Unit, Faculty of Health Sciences, Soroka University Medical Centre, Ben Gurion, University of the Negev, 84101 Beer Sheva, Israel. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study: Am Heart JI 2006 Jan;151(1):100.
39 KalioraAC, DedoussisGV, Schmidt H. – Department of Science of DieteticsrNutrition, Harokopio University of Athens, Greece. Dietary antioxidantsin preventing atherogenesis Atherosclerosis. 2005 Nov 25;
40 Hsiao G, Wang Y, Tzu NH, Fong TH, Seen MY, Lin KH, Chou DS Sheu JR Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombusformation. JLabQin Med. 2005Oct;146(4):216-26
41 Yilmaz § Atessahin A, Sahna E Karahan 1, Ozer S Protective effect of lycopene on adriamyan-induced cardiotoxicity and nephrotoxicity. Toxicology. 2006 Feb 1;218(2-3):164-71. Epub 2005 Dec 1.
[42] Sesso HD, Buring JE Norkus EP, Gaziano JM. Plasma lycopene, other carotenoids; and retinol and the risk of cardiovascular disease in men. Am JCin Nutr. 2005 May;81(5):990-7.
43 Sesso HD Cbrotenoidsandcardiovascular disease: what research gapsremain?Curr Opin Lipidol. 2006 Feb; 17(1): 11-16.
[44] Sesso HD, Buring JE; Norkus EP, Gaziano JM. – Division of Preventive Medicine, Department of Medicine, Brigham and Women’s, Hospital and Harvard Medical School, Boston, USA. Plasma lycopene, other carotenoids; and retinol and the risk of cardiovascular disease in women. Am J Cin Nutr. 2004 Jan; 79(1): 47-53.
[45] Rissanen TH, Voutilainen ┬º Nyyssonen K Salonen R, Kaplan GA, Salonen JT. University of Kuopio, Kuopio, Finland. Serum lycopene concentrations and carotid atherosclerosis the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Cin Nutr 2003 Jan;77(1):133-8
[46] Hak AE Stampfer MJ, Campos H, Sesso HD, Gaziano JM, Willett W, Ma J Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of USmale physicians: Circulation. 2003 Aug 19;108(7):802-7. Epub 2003 Aug 04.
47 AhujaKD, Pittaway JK Ball MJ. Effectsof olive oil and tomato lycopene combination on serum lycopene, lipid profile, and lipid oxidation. Nutrition. 2006 Jan 12.
48 Lee DH, G^oss MD, Jacobs J DR Association of Serum Carotenoids and Tocopherols with {gamma}-Glutaffiyltransferase: The Cardiovascular Risk Development in Young Adults(CARDIA) Study. Clin Chem. 2004 Jan 15.
[49] Hadley CW, Clinton SK Schwartz SJ. – The Department of Food Science and Technology, The James Cancer Hospital and Solove Research Institute, Cblumbus, USA. -The consumption of processed tomato productsenhancesplasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. JNutr 2003 Mar;133(3):727-32 [
50 Visioli F, Rso P, Grande S Galli C, Porrini M. Department of Pharmacological Science, University of Milan,Italy. Protective activity of tomatoproductson in vivo markersof lipid oxidation. Eur JNutr. 2003Aug;42(4):201-6.
51 Jonasson L, Wikby A, Olsson AG – Department of Cardiology, Heart Center, University Hospital, S581 85 Linkoping, Sweden. Low serum beta-carotene reflects immune activation in patientswith coronary artery disease. Nutr Metab Cardiovasc Ds. 2003 Jun; 13(3): 120-5.
52 Passi S    Stancato    A,    Aleo    E Dmitrieva A,    Littarru    GP.    Cfentro    Invecchiamento    Cfellulare,    I.D.I.    (IFCCS),    Foma,    Italy.    Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors 2003; 18(1-4): 113-24.
[53] Kerstin Wlpstein-GTobusch ; Johanna H. den Breeeijen; Dieterick E Giobbe ; Alimer Boeing ; Albert Hofman ; Jacqueline CD. Witherman. Dietary Antioxidant and Peripheral Arterial Disease. The Rotterdam Study. The American Journal of Epidemiology. AJE2001. Vol. 154 N0.2.
[54] Kaumudi JJoshipura; Frank B. Hu; JoAnn E Manson; Meier J. Stampfer; EricB. Rimm ; Frank E Spelzen; Graham Colditz; Alberto Ascherio; Bernard Resner ; DonnaSpiegelmam ; Water C Willet. The effect of Fruitsand Vegetable intake on Riskfor Coronary Heart Disease. Ann. Intern. Med. 2001; 134: 1106-1114.
55 Lenore Kohlmeier and Susan B. Hastings – Epidemiologic evidence of a role of carotenoids in cardiovascular disease prevention. Am J Clin Nutr 1995 : 62 (suppl) : 1370S6S
[56] Louis J. Ignarro , Maria Luisa Balestrieri, Claudio Napoli. Nutrition, physical activity and cardiovascular disease : an update. Review Cardiovascular Research 73 (2007) 326-340
[57] Atshshi Hozawa, D.R Jacobs, et … Relationship of circulating carotenoid concentrationswith several markersof inflammation, oxidative stressand endothelial dysfunction : the Coronary Artery Risk Development In Young Adult (CARDIA) / Young Adult Longitudinal Trend in Antioxidants(YALTA) study-Cardiovascular Research 73 (2007) 326-340
[58] H.D. Sesso, 3min Liu, JMichael Gaziano and JE Buring. Dietary Lycopene, Tomato based product and cardiovascular disease in women. The Journal of Nutrition. J Nutr 133 : 2336-2341,2003
[59] Marlene M. Most – Estimated phytochemical content of the Dietary Approachesto Stop Hypertension (DASH) Diet is higher than in the control study diet. J Am Det Ass. 2004- 104 :1725-1727
60 Paran Esther; Engelhard Yehiel, Inbal Hazan-Hallevy, Yoav Sharoni, Joseph Levy – Hypertension Unit, Soroka University medical
Center, Beer Sheva, Israel – Effect of standardized tomato extract on blood pressure^ endothelial function and plasma Lycopene level in treated hypertensive patients: American Journal of Hypertension Vol. 18 No. 5 Part 2- May 2005
[61] Stephen B Krifchevsky.    Department    of    Preventive    Medicine ,    University    of    Tennesee. Memphis.    B    Carotene,    Carotenoids and the prevention of (Coronary Heart Disease – J Nufr. 1999; Vol 129; 5-8
[62] Stephen B. Krichevinsky; Andrew J Bush ; Marco Pahor; Myran D. G^oss. Serum Carotenoidsand Markersof Inflammation in Nonsmokers American Jburnal of Epidemiology. AJE 2000 ; Vol. 152 N.11 ; 1065 -71
[63] A.V. Fao and SAgarwa. Department of Sciences ,University of Toronto, Ontario, Canada. Effect of diet and smoking on serum Lycopene and Lipid peroxidation. Nutritional Research , Vol 18, No 4 , p 713-721, 1998
[64] Tammy M. Bray, PhD – Dean and Professor College of Health and Human Sciences Oregon State University Corvallis- OF- Putative Anti-inflammatory Functions of Lycopene in Prevention of Cardiovascular Disease
65 Milde J] Bstner EF, GTassmann J. Department of Rant Sciences, Institute of Phytopathology, Laboratory for Applied Biochemistry, Munich Technical University, Freising-Weihenstephan, Germany. Synercpsticeffectsof phenolicsand carotenoids on human low-density lipoprotein oxidation. Mol Nutr Food Fes. 2007 Aug;51(8):956-61.
66 Steinberg D., Parthasarathy S, Care T.E, Khoo JC, Wifztum JL Beyond cholesterol: Modifications of low-density lipoprotein that increasesits atherogenicity. N Eng J Med 1989: 320:915-924.
67 ParfhasarathyS Mechanismsby which dietary antioxidantsmay prevent cardiovascular diseases J Medianal Food 1998 .
68 Street D.A., Comstock    GW.,    Salkeld    FtM., Sbhuep W.,    Klag    M.J    Sterum    antioxidants and myocardial    infarction.    Are    levels of carotenoidsand alpha-tocopherol risk factorsfor myocardial infarction? Circulation 1994; 90:1154-1161.
69 Kristenson M., Zieden B., Kuanaskiene Z, Binder LS, Bergdahl B., BwingB., AbaraviciusA., Fazinkoviene L, Calkauskas H., Olsson A. Antioxidant State and Mortality from Coronary Heart Disease in Lithuanian and Swedish Men: Concomitant Cross Sectional Study of Men Aged 50. BMJ 1997; 314:629-633.
[70] G. Riccioni,    B.    Mancini,    E Di llio, T. Bucdarelli,    N.DÔÇÖOrazio –    Protective effect    of    lycopene in    cardiovascular    disease    – European Fteviewfor Medical and Pharmacological Sciences 2008.
71 Linseisen J, Hoffmann J, Fiedl J, Wolfram G Effect of a single dose of antioxidant mixture (vitamin E, carotenoid^ on the formation of cholesterol oxidation products after ex vivo LDL oxidation in humans: Eur J Med Ffes 1998; 3:5-12.
72 Agarwal S, Fao A.V. Tomato lycopene and low-density lipoprotein oxidation: a human dietary intervention study. Lpids 1998; 33:981-984
[73] Lu Wang, Jl Michael Gaziano, Edward P Norkus, Julie EBuring, and Howard D. Sesso- Associations of plasma carotenoids with risk factorsand biomarkers related to cardiovascular disease in middle-aged and older women – Am J Clin Nutr. 2008 Sept.
[74] Frank B Hu, Eric B Fmm, Meir J Stampfer, Alberto Ascherio, Donna Spiegelman, and Water CWillett – Prospective study of major dietary patterns and risk of coronary heart disease in men1-3 -. Am JClin Nutr 2000;72:912-21.
[75] Edmond Kato Kabagambe, Jeremy Furtado, Ana Baylin, and Hannia Campos – Sbme Dietary and Adipose Tissue Carotenoids Are Associated with the Risk of Nonfatal Acute Myocardial Infarction in Costa Rica1,2 – J Nutr. 135:1763-1769, 2005.

References Lycopene and Prostate

1 Ansari M, Ansari S – Lycopene and prostate cancer. Future Oncol. 2005 Jjn;1(3):425-430.
2 Stacewicz-SSapuntzakisM, Bowen PE Role of lycopene and tomato productsin prostate health. Biochim BiophysActa 2005 May 30;1740(2):202-5. Epub 2005 Mar 13.
3 Ansari MS, Gupta NP Lycopene: a novel drugtherapy in hormone refractory metastatic prostate cancer. Urol Oncol. 2004 Sep-Oct;22(5):415-20.
4 Kaplan SA. Lycopene: modesof action to promote prostate health. J Urol. 2005 Aug; 174(2):679.
5 Mohanty NK, Saxena S Sngh UP, Goya NK, Arora FP Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. Urol Oncol. 2005 Nov-Dec;23(6):383-5.
6 Guns EE, Cowell SP – Department of Surgery, University of British Columbia, Canada. Drug Insight: lycopene in the prevention and treatment of prostate cancer. Nat Clin Pract Urol. 2005 Jan;2(1):38-43.
7 Fraser ML, Lee AH,    Binns CW.    -    Curtin    University    of    Technology,    Sbhool    of    Public    Health, GPO Box U 1987,    Perth    WA 6845, Australia. Lycopene and prostate cancer: emercjng evidence. Expert Rev Anticancer Ther. 2005Cct;5(5):847-54.
[8] Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, Dixon LB, Urban DA, Crawford ED, Hayes FB.. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):92-8.
9 EVerson KM, McQueen CE Lycopene for prevention and treatment of prostate cancer. Am J Health Syst Pharm. 2004 Aug 1;61(15):1562-6.
[10] Barber NJ, Barber … Lycopene and prostate cancer. Prostate Cancer Prostat ic Diseases 2002 Mar;5(1):6-12.
11 Hwang ES Bowen PE- Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells: Biofactors 2005;23(2):97-105.
[12] Bowen PE.    Selection    of    surrogate    endpoint    biomarkers    to    evaluate    the    efficacy    of    lycopene/tomatoes for the prevention/progression of prostate cancer. JNutr. 2005 Aug; 135(8) :2068S-70S
[13] Gann PH. – Intermediate biomarkersof lycopene/tomato effects in high-risk prostatic tissue. JNutr. 2005 Aug; 135(8):2065S7S
[14] Lu QY, Hung JC, Heber D, Go VL, Reuter VE Gordon-Cardo Q Scher HI, Marshall JR Zhang ZF. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Bomarkers Prev 2001 dil; 10(7)749-56
15 Chan JM,    Gann PH, Qovannucd    EL.    Role of    diet    in    prostate cancer development    and    progessionJ Clin    Chool.    2005 Nov 10;23(32):8152-60.
[16] Ansari MS Gupta NP. Bratt C. A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU Int. 2005 Feb; 95(3):453. BJU Int. 2005 Jan; 95(1):192.
[17] Cbermuller-Jevic UQQano-Martin E Corbacho AM, Eserich JP,van der Viet A, Vaacchi G, Cross CE Packer L . Lycopene inhibits the growth of normal human prostate epithelial cellsin vitro. JNutr. 2003 Nov;133(11):3356-60.
18 Hwang ES Bowen PE – Effects of tomato paste extracts on cell proliferation, cell-cyde arrest and apoptosis in LNCaP human prostate cancer cells: Biofactors. 2005;23(2):75-84.
19 Chang S    Erdman JW Jr,    Clinton    SK Vadiveloo    M,    Strom S┬º Yamamura    Y,    Duphorne    CM,    S^itz MR,    Amos Cl,    Contois JH, Gu X Babaian    FFJ,    Scardino FT, Hursting SD.    Relationship    between    plasma    carotenoids and    prostate    cancer.    Nutr Cancer. 2005;53(2):127-34.
[20] Krista AR, Schenk JM. Fred Hutchinson Cancer Research Center, Seattle, WA 98109-4686. Directionsfor future epidemiologcal research in lycopene and prostate cancer risk. J Nut r. 2005 Aug; 135(8) :2037S9S
[21] Giovannucci E – Tomato Products, Lycopene, and Prostate Cancer: A Review of the Epidemiological Literature. J Nutr. 2005 Aug; 135(8):2030S-2031S
22 Giovannucci E Clinton SK- Tomatoes, lycopene, and prostate cancer. ProcSocExp Biol Med 1998 Jjn;218(2):129-139
[23] Giovannucci E Ascherio A, Fimm EB, Stampfer MJ, ColditzGA, Willett WC- Intake of carotenoids and retinol in relation to risk of prostate cancer. JNatl Cancer Inst 1995 Dec 6;87(23): 1767-1776 .
24 Pastori M, Pfander H, Boscoboinik D, Azzi A- Lycopene in association with alpha-tocopherol inhibits at physiolocpcal concentrations proliferation of prostate carcinoma cells: Bochem Bophys Res Commun 1998 Sep 29;250(3):582-5
25 Gann PH, Ma J Giovannucci E Willett W, Sacks FM, Hennekens CH, Stampfer MJ – Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999 Mar 15;59(6):1225-30
26 Rao AV,    Fleshner    N, Agarwal    S-    Sbrum and tissue    lycopene and    biomarkersof    oxidation in prostate cancer    patients:    a case- control study. Nutr Cncer 1999;33(2):159-64
[27] Norrish AE, Jackson RT, Sharpe SJJ, Skeaff CM- Prostate cancer and dietary carotenoids. Am JEpidemiol 2000 Jan 15;151(2): 119-23
28 Pastori M, Pfander H, Boscoboinik D, Azzi A. Lycopene in association with alpha-tocopherol inhibitsat physiolocpcal concentrations proliferation of prostate carcinoma cells. Bochemical and Bophysica Research Communications 1998.
29 Matlaga BR Hall MC, SSindt D, Torti FM. – Response of hormone refractory prostate cancer to lycopene. JUrol 2001 Aug.
[30] Van Breemen RB.. How do intermediate endpoint markers respond to lycopene in men with prostate cancer or benign prostate hyperplasia?JNutr. 2005 Aug; 135(8):2062S-4S
[31] Clinton SK/ – Tomatoesor lycopene: a role in prostate carcinogenesis? JNutr. 2005 Aug; 135(8):2057S-9S
32 Slke Sdiwarz,    Lite    C Cbermuller-Jbvic,    Eva Hellmis,    et    al.    Lycopene    Inhibits    Disease    Progression    in Patients with Benigni Prostate Hyperplasia jI Nutr. 2008
[33] Limpens J Schroder FH, de Ridder CM, Bolder CA, Wildhagen MF, Obermuller-Jbvic- Combined lycopene and vitamin Etreatment suppresses the growth of PC-346Chuman prostate cancer cellsin nude mice. JNutr. 2006 May; 136(5): 1287-93.
34 Jan L, Du G) Lee AH, BinnsCW. Do dietary lycopene and other carotenoids protect against prostate cancer? Int J Cancer. 2004 Oct 28.
35 Clark PE;    Hall    MQ Borden LS Jr,    Miller    AA,    Hu JJ Lee WR    Stindt    D,    D’Agostino    R Jr,    Lovato J]    Harmon M, Torti FM. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology. 2006 Jun;67(6):1257-61.
36 Fbssinow JK, Balajee ASj Gtewanter RM, Ennis FD, Schiff PB, Katz AE Gteard CFt – Effects of lycopene and vitamin Eon gamma-irradiated prostate cancer cells Int J Radiat Oncol Biol Phys. 2003 Oct 1.
37 Rao AV,    Fleshner    N, Agarwal    Si    Serum and    tissue    lycopene and    biomarkers of    oxidation    in    prostate    cancer    patients:    a case control study. Nutr Cancer 33:159-164, 1999
[38] Edward Giovannucd – Does Prostate-Specific Antigen Screening Influence the Results of Studies of Tomatoes* Lycopene, and Prostate Cancer Risk? JNQ Vol. 99, Issue 14- July 18, 2007
39 Freeman VL, Mohsen M, YongSj Pyle J] Wan Y, Arvizu-Durazo R Liao Y frostatic Levels of Tocopherols, Carotenoids, and Retinol in Relation to Plasma Levelsand Self-Reported Usual Dietary Intake, Am. J Epidemiology, Vol 151(2):109-118, January 15, 2000
40 Sonn GA, Aronson W, Lit win MS Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis. 2005 Aug 30; Prostate Cancer and Prostatic Diseases advance online publication, 30 August 2005.
41 Almushatat ASj Talwar D, McArdle PA, Williamson Q Sattar N, Oreilly DSj Underwood MA, McMillan DC Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patientswith prostate cancer. Int J Cancer. 2005 Aug 16;
[42] Clinton SK Emenhiser Q Schwartz SJ Bostwick DG, Williams AW, Moore BJ, Erdman jW J – cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers PTev 1996 Oct ;5(10):823-833
43 Shvastava AR Dalela D Prostate cancer: altering the natural history by dietary changes: Natl Med J India. 2004 Sep-Oct;17(5):248-53.
44 Hwang EE] Bowen PE Department of Human Nutrition, University of Illinois, Chicago, Illinois, U.SA. Cell Cyde Arrest and Induction of Apoptosis by Lycopene in LNCaP Human Prostate Cancer Cells. JMed Food. 2004Fall;7(3):284-9.
45 Bosetti C Talamini R Montella M, Negri E Conti E Franceschi S La Vecchia C Retinol, carotenoids and the risk of prostate cancer: Acase-control study from Italy. Int J Cancer. 2004 Nov 20;112(4):689.
[46] Siler U, Herzog A, Spitzer V, Sfeifert N, Denelavas A, Hunziker PB, Barella L, Hunziker W, Lein M, Goralczyk R Wertz K Lycopene effects on rat normal prostate and prostate tumor tissue. JNutr. 2005 Aug; 135(8) :2050S-2S
[47] Gupta S Department of Urology, Case Western Reserve University, Ceveland, OH 44106, USA.    frostate cancer chemoprevention: current statusand future prospects. Toxicol Appl Pharmacol. 2007 Nov 1;224(3):369-76. Epub 2006 Nov 15.
[48] Siler U, Barella L, Spitzer V, Sohnorr J] Lein M, Goralczyk R Wertz K Lycopene and Vitamin E interfere with autocrine^paracrine loops in the Dunning prostate cancer model. FASEB J. 2004 Apr 14
[49 TangL, Jn T, Zfeng X, Wang JB – Lycopene inhibitsthe growth of human androgen-independent prostate cancer cellsin vitro and in BALE/ c nude mice. J Nut r. 2005 Feb; 135(2) :287-90.
50 Kristal    AR    – Cancer    Prevention    Program,    Fred    Hutchinson Cancer    Research    Program,    Seattle,    Washington 98109-1024, USA. Vitamin A, retinoids and carotenoids aschemopreventive agentsfor prostate cancer.JUrol. 2004 Feb;171(2 Pt 2):S54-8.
[51] Wu K Erdman JW J”, Schwartz SJ Ratz EA, Leitzmann M, Cinton SK DeG”off V, Willett WC, Govannucci Ei Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers PTev.    2004 Feb;13(2):260-9.
52 Kim HS Bowen P, Chen L, Duncan Q Ghosh L, Sharifi R Christov K Effects of tomato sauce consumption on apoptoticcell death in prostate benign hyperplasia and carcinoma. Nutr Cancer. 2003;47(1):40-7.
[53] Forbes K Gillette K Sehgal 1. Lycopene increases urokinase receptor and fails to inhibit growth or connexin expression in a metastatically passaged prostate cancer cell line: a brief communication. Exp Biol Med (Maywood). 2003 Sep;228(8):967-71.
54 Boileau TW, Liao Z Kim S Lemeshow S Erdman JW J”, Clinton SK frostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated ratsfed tomato powder, lycopene, or energy-restricted diets. JNatl Cancer Inst. 2003 Nov5.
55 Pohar KS Gong MQ Bahnson R Miller EC, Clinton SK Tomatoes, lycopene and prostate cancer: a clinician’s guide for counseling those at risk for prostate cancer. World J Urol. 2003 May;21(1):9-14. Epub 2003 Mar 22.
[56] Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJL Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am JEpidemiol 2003 Feb 15; 157(4):335-44.
[57] Valeri V. Mossine, Pankaj Chopra, and Thomas P Mawhinney – Interaction of Tomato Lycopene and Ketosamine against Rat Prostate Tumorigenesis – Cancer Ftes2008;68(11):4384-91
58 Gann PH, Khachik F – Tomatoesor lycopene versus prostate cancer: isevolution anti-reductionist? J Nall Cancer Inst. 2003 Nov 5;95(21):1563-5.
[59] Kotake-Nara E Kushiro M, Zhang H, Sugawara T, Miyashita K, Nagao A. CarotenoidsAffect Proliferation of Human Prostate Cbncer Cfells JNutr 2001 Dec;131(12):3303-3306
[60] Giovannucci E Fimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of tomato products, lycopene, and prostate cancer risk. JNatl Cancer Inst 2002 Mar 6;94(5):391-8
61 Grant WB- Calcium, lycopene, vitamin D and prostate cancer. Prostate 2000 Feb 15;42(3):243
[62] Vogt TM, Mayne ST, Graubard BI, Swanson CA and GM, Sowell AL Sohoenberg JB, Greenberg FS Hoover FN, Hayes FB, Ze^er FG Sterum lycopene, other serum carotenoids; and risk of prostate cancer in USBIacksand Whites Am J Epidemiol 2002 Jun 1
[63] Giovannucci E -A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med (Maywood) 2002 Nov;227(10):852-9
[64] Minorsky FV. – Department of Natural Sciences, Mercy College, Dobbs Ferry, NY10522, USA. Lycopene andthe prevention of prostate cancer: the love apple livesup to itsname. Plant Physiol 2002 Nov;130(3):1077
[65] KucukO, Sarkar FH, DjuricZ, Sakr W, Poliak MN, Khachik F, Banerjee M, Bertram JS Wood GPU”. Effectsof lycopene supplementation in patientswith localized prostate cancer. Exp Bol Med (Maywood) 2002 Nov;227(10):881-5.
[66] Kim L, Fao AV, F&o LG. – Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada. Effect of Lycopene on Prostate LNCaF Cancer Cellsin Culture. JMed Food 2002 Winter;5(4):181-7
[67] Hadley CW, Miller EC, Schwartz SJJ, Clinton SK. Tomatoes, lycopene, and prostate cancer: progressand promise. Exp Bol Med (Maywood) 2002 Nov;227(10):869-80
68 Heshner N, Agarwal S Fao V. Serum and tissue lycopene and biomarkersof oxidation in prostate cancer patients: a case control study. Prostate Cancer ProstaticDis 2000 Dec;3(S1):S13
69 Miller EC, Govannuca E Erdman JW 4, Bahnson F Schwartz SJ Qinton SK- Tomato products, lycopene, and prostate cancer risk. Urol Clin North Am 2002 Feb;29(1):83-93
[70] Bowen P,    Chen L, Stacewicz-Sapuntzakis M,    Duncan C,    Sharifi    F Ghosh    L,    Kim    HS Christov-Tzelkov    K,    van Breemen Ft -Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkersof carcinogenesis Exp Biol Med (Maywood) 2002 Nov;227(10):886-93
[71] Ang Liu, NatasaPajkovic, Yan Pang, Dongwei Zhu, Barbara Calamini, Andrew L Mesecar, and Fchard B. van Breemen – Absorption and subcellular localization of lycopene in human prostate cancer cells – Mol Cancer Ther 2006; 5(11):2879-85
72 Hsing AW, Comstock GW, Abey H, Polk BF – Sferologic precursors of cancer. Retinol, carotenoids; and tocopherol and risk of prostate cancer. JNatl Cancer Inst 1990Jjn6;82(11):941-946 –
[73] Olson KB, RentaKJ- VitaminsA and E further duesfor prostate cancer prevention. JNatl Cancer Inst 1998 Mar 18;90(6):414-415 – Comment on: JNatl Cancer Inst 1998 Mar 18;90(6):440-6
[74] Kristal AF, Cohen JH – Cancer Prevention Ftesearch Program, Fred Hutchinson Cancer Ftesearch Cfenter, battle, WA, USA. Invited commentary: tomatoes, lycopene, and prostate cancer. How strong isthe evidence? Am J Epidemiol 2000 Jan 15.
[75] JessicaK Campbell, KirstieOanene-Adams, Brian L Lindshield, ThomasW.-M. Boileau, Steven K Cinton, and John W. Erdman, J”. – Tomato Phytochemicalsand Prostate Cancer Risk1,2 – J Nutr. 134: 3486S-3492S 2004
[76] Guttenplan JB, Chen M, KosinskaW, Thompson S Zhao Z, Cohen LA – Division of BasicSciences/Bochemistry, New York University, Dental Cfenter, 345 E 24th St., New York, 10100, NY, USA – Effectsof a lycopene-rich diet on spontaneousand benzo[a]pyrene induced mutagenesis in porstate, colon, and lung of the lac Z mouse. Cancer Lett 2001 Mar 10;164(1):1-6
[77] Imaida K Tamano S Kato K, Ikeda Y, Asamoto M, Takahashi S Nir Z Murakoshi M, Nishino H, Shirai T Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis Carcinogenesis 2001 Mar;22(3):467-72
78 Mucci LA, Tamimi F Lagiou P, Trichopoulou A, Benetou V, Spanos E Trichopoulos D. Are dietary influenceson the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int 2001 Jun;87(9):814-20
79 De laTaille, A.; Katz, A.; Vacherot, F.; Saint, F; Salomon, L.; Cicco, A.; Abbou, C. C.; Chopin, D. K – Cancer of the prostate: influence of nutritional factors: Vitamins, antioxidants and trace elements- Presse Med Vol 30 No. 11 2001 Mar 24 PP. 557-60
[80] Schroder, Fritz H.;    Kranse, Res;    Dijk, Mathilde    A.;    0om,    Jan FI.    M.; van    Kemenade, Monique;    Dagnelie,    Peter C; Tijburg,    Lianne M.; Weststrate, Jan A – Fbtterdam, Netherlands – Dietary intervention in prostate cancer patients: Results of a randomized, double blind placebo controlled cross-over study. Journal of Urology VOL. 165 NO. 5 Supplement May, 2001 FP. 65.
[81] Kucuk O, Sarkar FH, Sakr W, Djuric Z Pbllak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS Crissman JD, Pontes EEJ, Wood DP Jo Fhase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Rev 2001 Aug; 10(8):861 -868
82 Kucuk O, Wood DP J”. – Response of hormone refractory prostate cancer to lycopene. JUrol 2002 Feb;167(2 R 1):651
[83] Schuurman AG, Goldbohm FA, Brants HA, van den Brandt PA. – A prospective cohort study on intake of retinol, vitaminsCand E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Gent rol 2002 Aug; 13(6) :573-82 –
[84] KucukO. – Barbara Ann KarmanosCancer Institute, Wayne State University, Detroit, Michigan 48201, USA. Chemoprevention of prostate cancer. Cancer Metastasis Rev 2002;21(2):111-24
[85] Ansari MSj GuptaNP, Hemal AK Department of Urology, All India Institute of Medical Sciences, New Delhi-110029, India. Chemoprevention of carcinoma prostate: a review. Int Urol Nephrol. 2002;34(2):207-14.
[86] John W. Erdman Jr., Nikki A. Ford, and Brian L. Lindshield – Are the health attributesof lycopene related toitsantioxidant function? ArchBochem Bophys 2009 March 15; 483(2): 229-235
[87] Steven K Clinton, M.D., Ph O.. The Dietary Antioxidant Network and FVostate Carcinoma – Ffeceived July 26, 1999; accepted August 4, 1999. 1999 American Cancer Sbaety
[88] Ulrike Peters, Michael F. Leitzmann, Nilanjan Chatterjee, Yinghui Wang, Demetrius Albanes, Edward P. Gelmann, Marlin D. Friesen, Elio Riboli, and Richard B. Hayes- Serum Lycopene, Other Carotenoids; and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiology,Bomarkers& Revention 2007 [
[89] Hoyoku Nishino, Michiaki Murakoshi, Tsunehiro Ii, Manabu Takemura, Masashi Kuchide, Motohiro Kanazawa, Xiao Yang Mou, Saeri Wada,    Mitsuharu    Masuda,    Yasuhito    Chsaka,    Shingo Yogosawa,    Yoshiko    Satomi and Kenji    Jnno –    &pan    – Carotenoids in cancer chemoprevention. Chncer and Metastaa’s Fbviews21: 257-264, 2002.
[90] Edward Giovannucd – Does Prostate-Specific Antigen Screening Influence the Results of Studies of Tomatoes; Lycopene, and Prostate Cancer Risk? JNQ – Vol. 99, Issue 14 July 18, 2007
[91] PROSTATE PRESENTATION : Emma Guns, Ph.D. Assistant Professor, UBC-Head Head, Analytical Pharmacology – The role of lycopene in prostate cancer prevention and therapy.
92 Norrish, Alan E; Jackson, Rodney T.; Sharpe, Susan J; Skeaff, G Murray- Rostate Cancer and Dietary Carotenoids: American Jburnal of Epidemiology. 151 (2):119-123, January 15, 2000
[93] Qaudine J. Kavanaugh , Paula R. Trumbo , Kathleen C. Ellwood – The U.S Food and Drug AdministrationÔÇÖs Evidence-Eased Review for Qualified Health Claims: Tomatoes; Lycopene, and Cancer- J Natl Cancer Inst 2007;99:1074- 85